SCHEMBL3031653

SCHEMBL3031653

CCc1c(Cl)cc(N)c(O)c1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.37
THRB P10828 2/20 0.37
HSD17B10 Q99714 6/20 0.36
HPGD P15428 5/20 0.36
TSHR P16473 3/20 0.36
ALOX15 P16050 3/20 0.36
CYP3A4 P08684 3/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 2/20 0.36
USP2 O75604 2/20 0.36
ESR2 Q92731 2/20 0.36
MEN1 O00255 2/20 0.36
HTT P42858 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 1/20 0.36
EGFR P00533 1/20 0.36
ESR1 P03372 1/20 0.36
ERBB2 P04626 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31532254 1.00 GAA (0.37) GAATHRBHSD17B10HPGDTSHR
Hydrochloric Acid SCHEMBL8075443 0.98 GAA (0.36) GAATHRBHSD17B10HPGDTSHR
SCHEMBL8083612 0.85 GAA (0.34) GAATHRBHSD17B10HPGDTSHR
Hydrochloric Acid SCHEMBL8075471 0.83 GAA (0.33) GAATHRBHSD17B10HPGDTSHR
SCHEMBL8088989 0.82 HPGD (0.42) GAAHSD17B10HPGDLMNAMAPT
SCHEMBL7761763 0.81 CYP1A2 (0.41) GAAHSD17B10TSHRALOX15CYP3A4
Hydrochloric Acid SCHEMBL8088632 0.80 HPGD (0.41) GAAHSD17B10HPGDLMNAMAPT
SCHEMBL12774727 0.78 SIRT1 (0.47) GAATHRBHSD17B10HPGDTSHR
SCHEMBL9538794 0.76 HPGD (0.33) GAATHRBHSD17B10HPGDTSHR
SCHEMBL5526674 0.75 THRB (0.46) GAATHRBHSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-9100417-A None JP disclosed
US-9522906-B2 Tetrahydroquinoline analogues as muscarinic agonists ACADIA PHARMACEUTICALS, INC. (US) 2016-12-20 US disclosed
US-20140221364-A1 TETRAHYDROQUINOLINE ANALOGUES AS MUSCARINIC AGONISTS ACADIA PHARMACEUTICALS, INC. (US) 2014-08-07 US disclosed
US-8680115-B2 Tetrahydroquinoline analogues as muscarinic agonists ACADIA PHARMACEUTICALS, INC. (US) 2014-03-25 US disclosed
US-20100216840-A1 BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS ACADIA PHARMACEUTICALS INC. (US) 2010-08-26 US disclosed
US-20090239903-A1 TETRAHYDROQUINOLINE ANALOGUES AS MUSCARINIC AGONISTS ACADIA PHARMACEUTICALS, INC. (US) 2009-09-24 US disclosed
US-7576078-B2 Tetrahydroquinoline analogues as muscarinic agonists ACADIA PHARMACEUTICALS, INC. (US) 2009-08-18 US disclosed
US-7576100-B2 Muscarinic agonists ACADIA PHARMACEUTICALS, INC. (US) 2009-08-18 US disclosed
US-7550459-B2 Neurodegenerative diseases, psychological disorders; e.g. 4-[3-(3a -Cyclopropylmethoxy-8-azabicyclo[3.2.1]oct-8-yl)-2-methylpropyl]-4H-benzo[1.4]oxazin-3-one ACADIA PHARMACEUTICALS, INC. (US) 2009-06-23 US disclosed
US-20080070948-A1 BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS ACADIA PHARMACEUTICALS INC. (US) 2008-03-20 US disclosed
EP-0250954-A2 Colour-photographic recording material with a dye releaser for blue-green dyes, and a colour picture produced with these dyes Agfa-Gevaert AG (DE) 1988-01-07 EP disclosed
EP-0243100-A2 Method for processing light-sensitive silver halide color photographic material KONICA CORPORATION (JP) 1987-10-28 EP disclosed
EP-0243096-A2 Method for processing a light-sensitive silver halide color photographic material KONICA CORPORATION (JP) 1987-10-28 EP disclosed
US-4686177-A CYAN COUPLER FUJI PHOTO FILM CO., LTD. (JP) 1987-08-11 US disclosed
US-4670608-A CATALYTIC CHLORINATION OF 1-ALKYL-4-NITROBENZENE BAYER AKTIENGESELLSCHAFT (DE) 1987-06-02 US disclosed
US-4623616-A DIFFUSIONPROOF COUPLER, TRIAZINE HARDENING AGENT KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1986-11-18 US disclosed
EP-0175151-A1 2,4-Dichloro-3-alkyl-6-nitrophenols and process for their preparation BAYER AG (DE) 1986-03-26 EP disclosed
US-4564590-A Silver halide photographic material KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1986-01-14 US disclosed
EP-0157363-A2 Silver halide photografic material KONICA CORPORATION (JP) 1985-10-09 EP disclosed
EP-0156377-A1 Silver halide photographic material KONICA CORPORATION (JP) 1985-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070948-A1 BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS CHRM4, CHRM1, CHRM2 GAA 3236/4885THRB 203/4885HSD17B10 4564/4885
US-20140221364-A1 TETRAHYDROQUINOLINE ANALOGUES AS MUSCARINIC AGONISTS CHRM3, CHRM5, CHRM2 GAA 1783/4885THRB 237/4885HSD17B10 1962/4885
US-20090239903-A1 TETRAHYDROQUINOLINE ANALOGUES AS MUSCARINIC AGONISTS CHRM3, CHRM5, CHRM2 GAA 1783/4885THRB 237/4885HSD17B10 1962/4885
US-20100216840-A1 BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS CHRM4, CHRM1, CHRM2 GAA 3236/4885THRB 203/4885HSD17B10 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.